Neutralizing antibody: a savior in the Covid-19 disease
SL Gupta, RK Jaiswal - Molecular biology reports, 2022 - Springer
Coronavirus outbreak was declared a pandemic by World Health Organization (WHO) in
March 2020. The pandemic has led to a devastating loss of life. It has shown us how …
March 2020. The pandemic has led to a devastating loss of life. It has shown us how …
[HTML][HTML] Broadly neutralizing antibodies against COVID-19
The COVID-19 pandemic caused by SARS-CoV-2 has led to hundreds of millions of
infections and millions of deaths, however, human monoclonal antibodies (mAbs) can be an …
infections and millions of deaths, however, human monoclonal antibodies (mAbs) can be an …
[HTML][HTML] Neutralizing antibodies targeting SARS-CoV-2 spike protein
S Xiaojie, L Yu, Y Guang, Q Min - Stem cell research, 2021 - Elsevier
SARS-CoV-2 causing the worldwide pandemic has changed people's life in multiple aspects
dramatically since it's first identified in Wuhan, China at the end of 2019. While the numbers …
dramatically since it's first identified in Wuhan, China at the end of 2019. While the numbers …
Broad strategies for neutralizing SARS-CoV-2 and other human coronaviruses with monoclonal antibodies
Z Ling, C Yi, X Sun, Z Yang, B Sun - Science China Life Sciences, 2023 - Springer
Antibody therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have been
approved in many countries, with most being developed based on the original strain of …
approved in many countries, with most being developed based on the original strain of …
Analysis of the molecular mechanism of SARS-CoV-2 antibodies
D Jin, J Wei, J Sun - Biochemical and biophysical research communications, 2021 - Elsevier
A newly-emergent beta-coronavirus, SARS-CoV-2, rapidly has become a pandemic since
2020. It is a serious respiratory disease and caused more than 100 million of deaths in the …
2020. It is a serious respiratory disease and caused more than 100 million of deaths in the …
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
COVID-19 pandemic is a global public health emergency. Despite extensive research, there
are still few effective treatment options available today. Neutralizing-antibody-based …
are still few effective treatment options available today. Neutralizing-antibody-based …
The development of neutralizing antibodies against SARS-CoV-2 and their common features
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide
severe coronavirus disease 2019 (COVID-19) pandemic since December 2019. There is a …
severe coronavirus disease 2019 (COVID-19) pandemic since December 2019. There is a …
Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives
CM Batista, L Foti - International Immunopharmacology, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has been declared by the World Health
Organization (WHO) as a pandemic since March 2020. This disease is caused by severe …
Organization (WHO) as a pandemic since March 2020. This disease is caused by severe …
[HTML][HTML] Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
JP Jaworski - biomedical journal, 2021 - Elsevier
The SARS-CoV-2 pandemic has caused unprecedented global health and economic crises.
Several vaccine approaches and repurposed drugs are currently under evaluation for safety …
Several vaccine approaches and repurposed drugs are currently under evaluation for safety …
Neutralizing anti-spike monoclonal antibodies for COVID-19 in vulnerable populations: lessons learned and future directions
RR Razonable - Expert Opinion on Biological Therapy, 2023 - Taylor & Francis
Introduction Anti-spike monoclonal antibodies were highly effective for prophylaxis and early
treatment of mild-to-moderate COVID-19 in high-risk populations. Areas covered This article …
treatment of mild-to-moderate COVID-19 in high-risk populations. Areas covered This article …